Goldman Sachs’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,600
Closed -$456K 6363
2017
Q4
$456K Sell
10,600
-13,900
-57% -$641K ﹤0.01% 4897
2017
Q3
$1.22M Sell
24,500
-2,400
-9% -$116K ﹤0.01% 4411
2017
Q2
$1.29M Buy
26,900
+11,800
+78% +$564K ﹤0.01% 4230
2017
Q1
$683K Sell
15,100
-27,400
-64% -$1.16M ﹤0.01% 4723
2016
Q4
$1.72M Sell
42,500
-4,900
-10% -$193K ﹤0.01% 3987
2016
Q3
$1.81M Buy
47,400
+31,900
+206% +$1.28M ﹤0.01% 3923
2016
Q2
$649K Sell
15,500
-1,400
-8% -$57.4K ﹤0.01% 4601
2016
Q1
$679K Sell
16,900
-3,400
-17% -$137K ﹤0.01% 4435
2015
Q4
$866K Buy
20,300
+4,500
+28% +$207K ﹤0.01% 4442
2015
Q3
$750K Sell
15,800
-18,500
-54% -$942K ﹤0.01% 4753
2015
Q2
$1.7M Buy
34,300
+13,100
+62% +$664K ﹤0.01% 4011
2015
Q1
$1.05M Sell
21,200
-900
-4% -$43K ﹤0.01% 4426
2014
Q4
$1.01M Buy
22,100
+12,700
+135% +$616K ﹤0.01% 4552
2014
Q3
$530K Sell
9,400
-19,200
-67% -$1.03M ﹤0.01% 5216
2014
Q2
$1.52M Sell
28,600
-9,000
-24% -$478K ﹤0.01% 4281
2014
Q1
$1.97M Buy
+37,600
New +$1.9M ﹤0.01% 3978
2013
Q4
Sell
-25,800
Closed -$1.31M 6791
2013
Q3
$1.31M Sell
25,800
-3,500
-12% -$178K ﹤0.01% 4345
2013
Q2
$1.51M Buy
+29,300
New +$1.56M ﹤0.01% 4002

Other funds holding SNY

Goldman Sachs's SNY Position: Q1 2026 in Review

Goldman Sachs increased its Sanofi (SNY) stake by 31% in Q1 2026, buying an estimated $28.2M and bringing the position to 2,582,456 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #905.

Goldman Sachs first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Goldman Sachs held 2,582,456 shares of Sanofi worth $124M as of Q1 2026.
  • Goldman Sachs bought 604,853 Sanofi shares in Q1 2026, an estimated $28.2M.
  • Sanofi made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #905 holding.
  • Goldman Sachs first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Sanofi position peaked at $211M in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.